The Agency for Healthcare Research and Quality has conducted numerous initiatives in hopes of preventing hospital readmissions, but a recently proposed project would examine ways to achieve this goal with a focus on the primary care setting.
The Agency for Healthcare Research and Quality (AHRQ) has conducted numerous initiatives in hopes of preventing hospital readmissions, but a recently proposed project would examine ways to achieve this goal with a focus on the primary care setting.
In its request for the project’s approval by the Office of Management and Budget, AHRQ outlined the goals of the research project and invited public comments on the proposal. The comment period will be open until April 14.
Hospital readmissions, according to the proposal, are a key indicator of healthcare quality and present increased opportunities for medical errors that can endanger patients. As such, reducing the number of preventable hospital readmissions has been a prominent goal of agencies like CMS, which implemented the Hospital Readmissions Reduction Program in 2012 to incentivize hospitals to lower their readmission rates.
AHRQ has conducted a number of efforts to develop evidence-based guidelines “largely focused on enhancing practices occurring within the hospital setting,” such as Project BOOST (Better Outcomes by Optimizing Safe Transitions). Although primary care settings have often been mentioned in these projects, literature focusing specifically on the role of primary care in preventing readmissions has been scarce.
To remedy this gap in guidance, AHRQ has proposed The Re-engineered Visit for Primary Care (REV), a 30-month project that will gather evidence from 9 primary care sites and explore which factors during each visit could be linked with hospital discharge and admissions. The proposal identified 7 data collection tasks that will be performed as part of the research:
Through these interviews and surveys, the researchers hope to identify which transitional care processes have the greatest effect on patient outcomes, including readmissions, and how they can be optimized. These findings, they wrote, will “provide insight on the components and themes that should be part of a re-engineered visit that will ultimately inform an effective intervention that can be tested in a diverse set of primary care clinics.”
The annual respondent burden, a required component of federal agency information collection activity proposals, was estimated at $11,500.30. This figure takes into account the anticipated hours per response and average hourly wages of the primary care staff, patients, and social workers to be interviewed in the project.
This estimated burden pales in comparison to the $41.3 billion cited in the proposal as the annual hospital costs of readmissions. By gathering data on opportunities for improvement in primary care, the research project could “address the important and unfulfilled need to improve patient safety and reduce avoidable readmissions within the primary care context,” according to the proposal.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More